about
High-grade glioma management and response assessment-recent advances and current challengesLongitudinal Brain Magnetic Resonance Imaging CO2 Stress Testing in Individual Adolescent Sports-Related Concussion Patients: A Pilot Study.Perfusion MRI: the five most frequently asked clinical questions.Perfusion MRI: the five most frequently asked technical questionsUse of contrast media in neuroimaging.Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery.Principles of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging.[Magnetic resonance imaging in clinical diagnosis of dementia]Neuroimaging findings in pediatric sports-related concussion.Magnetic Resonance Imaging and Computed Tomography of the Brain-50 Years of Innovation, With a Focus on the Future.Perfusion MRI in CNS disease: current concepts.[Working memory in healthy subjects and schizophrenics: studies using BOLD fMRT][Sellar tumors][Functional imaging for brain tumors (perfusion, DTI and MR spectroscopy)]Protocol design for high relaxivity contrast agents in MR imaging of the CNS.In vivo quantification of brain volumes in subcortical vascular dementia and Alzheimer's disease. An MRI-based study.Magnetically labeled water perfusion imaging of the uterine arteries and of normal and malignant cervical tissue: initial experiences.Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base.Partially resected gliomas: diagnostic performance of fluid-attenuated inversion recovery MR imaging for detection of progression.MR microcirculation assessment in cervical cancer: correlations with histomorphological tumor markers and clinical outcome.[Visualization of radiation effects on the central nervous system].Intravoxel Incoherent Motion Metrics as Potential Biomarkers for Survival in Glioblastoma.Disk displacement, eccentric condylar position, osteoarthrosis - misnomers for variations of normality? Results and interpretations from an MRI study in two age cohorts.Gadobenate dimeglumine (MultiHance) in MR imaging of the CNS: studies to assess the benefits of a high relaxivity contrast agent.Pathologic skeletal muscle perfusion in patients with myositis: detection with quantitative contrast-enhanced US--initial results.Prevalence of clinical and radiographic signs of osteoarthrosis of the temporomandibular joint in an older persons community.MR imaging of CNS tumors: are all contrast agents created the same?Contralateral recurrence of tumefactive demyelinationMagnetic resonance imaging using gadolinium-based contrast agents.Retirement-from-sport considerations following pediatric sports-related concussion: case illustrations and institutional approach.Multidisciplinary Management of Pediatric Sports-Related Concussion.Renal arteries: optimization of three-dimensional gadolinium-enhanced MR angiography with bolus-timing-independent fast multiphase acquisition in a single breath hold.Percutaneous vascular intervention based on gadolinium-enhanced MR angiography.Multiphase magnetic resonance angiography of the abdominal and pelvic arteries: results of a bicenter multireader analysis.Comparison of automated brain segmentation using a brain phantom and patients with early Alzheimer's dementia or mild cognitive impairment.Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury.High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study.Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?[MR spectroscopy in dementia].
P50
Q26740664-3D1711B3-C0B9-42CB-9E54-5E225BE4B4A5Q27318222-B2142754-25D6-42A4-BD10-88D261E20A87Q30416198-8925EA0C-48CC-4E99-B6FC-DC17EBB5BF61Q30421969-0E27F62E-41B3-4153-B92B-BB8EA18E8795Q30574378-35A39D14-6BBD-4F1F-8234-CA6134CBD1B5Q30586979-C7B3493B-E88D-46DF-9EB6-3E2F8FEDBB50Q30818733-2241A135-0EAA-4840-B1A3-3B4BC8BF26D7Q30822926-2A94B7E7-3F47-4B2D-8A10-8758C38AFA2CQ30962542-B0C7A8A6-BEF1-4E93-99C7-9EA12B6A69CEQ30967131-07C600CC-ABF5-41B3-AD58-4CCC4A0B0BB2Q30980191-4A6A5B27-4F59-4750-B037-5E4A0194217CQ30981082-37DD5A39-0A49-4AD8-8B31-F7C43E4DFB23Q31109753-A78EE1F4-EEC3-458F-86A0-0548CB9F60A2Q31112761-059DB9E9-907B-47EF-887F-5A181FD2284AQ31165119-B5945262-0776-40CB-B4E2-56DF168CE216Q32000769-338864CB-4A7B-44D7-9DA1-FEEA92B31927Q32061442-16923F36-A5DE-4513-94BD-7E1994E5E9FBQ33270835-141B86D6-21DD-4028-B8A3-652746875187Q33533555-200C6E99-3804-4613-93A5-8A475D1630A4Q33744666-A88D6688-3D32-462B-83FB-E369268931D9Q34220560-7C109794-9D8D-4770-9A95-5B7D7FE1EBB7Q36069929-28B583F0-5C10-42CB-A0F1-D9871DC26B6FQ36195515-3383FCE9-01D0-49A7-AB0B-4E4F87595767Q36233020-819C08C4-936A-4722-9A80-6A386C06A195Q36350058-B0B90FDA-3CF0-4E59-916F-3D8663244A86Q36461177-12B9970B-AE5A-4635-B311-71FF0662B945Q36478294-5A15C05B-A5CF-4403-8A64-11774B6EB2EAQ36589868-DE481B6B-5F0D-4158-A55A-870F7BEEF932Q38183241-AA88BE80-F45F-4424-AEC3-1D7FC8035183Q38794914-C284A265-2F0D-4110-B0CA-4F0B7C46F1D3Q38988646-AA834ECF-433F-4A5D-888A-3B57F41140C0Q39509546-30F30262-9B2C-4553-B678-CA4AC6632856Q39540798-C35D59EE-E6A1-49B9-943E-4E97F2EDE7DBQ39588144-CD4060D0-878D-41EC-A51E-422D13BD125CQ40299745-E3EF2C45-84D5-4BC6-B2CD-57E91EEBA0EFQ40526881-054D87EE-42EA-4227-AB8D-F445557EB0B7Q41259845-F12569AA-C7F6-4195-810F-3D9689A0ABEFQ42662363-1677B57D-009F-4830-B0A8-CF2D154FA3D3Q42911616-3E2D1668-A770-420C-AF44-C89E4239C0CDQ43019786-48AE0425-2796-4EFB-8299-AA7CE225395E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marco Essig
@ast
Marco Essig
@en
Marco Essig
@es
Marco Essig
@nl
type
label
Marco Essig
@ast
Marco Essig
@en
Marco Essig
@es
Marco Essig
@nl
prefLabel
Marco Essig
@ast
Marco Essig
@en
Marco Essig
@es
Marco Essig
@nl
P106
P1153
55576467900
P21
P31
P496
0000-0002-7964-2297